TUESDAY, Sept. 21, 2021 (HealthDay Information) — Getting a second dose of the Johnson & Johnson COVID-19 vaccine considerably elevated its safety, the corporate introduced Tuesday.
Based on the outcomes of a brand new medical trial, two doses of the vaccine increase immunity to 94 p.c from the 74 p.c provided by a single dose, the corporate mentioned in a press release.
“Our single-shot vaccine generates robust immune responses and long-lasting immune reminiscence. And, when a booster of the Johnson & Johnson COVID-19 vaccine is given, the energy of safety towards COVID-19 additional will increase,” Mathai Mammen, M.D., Ph.D., international head of Janssen Analysis and Growth at Johnson & Johnson, mentioned within the assertion.
Two photographs are additionally 100% efficient towards a extreme bout of illness, the corporate claimed. However that estimate isn’t sure, The New York Occasions reported.
The brand new knowledge have been submitted to the U.S. Meals and Drug Administration. For the reason that single-dose Johnson & Johnson vaccine was accredited in February, practically 15 million People have gotten it, The Occasions mentioned.
The New York Occasions Article
Adblock check (Why?)